During the past decade, Langenhoven Drive Oncology Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Langenhoven Drive Oncology Centre" #1 collaborator was "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Langenhoven Drive Oncology Centre" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Early Breast Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Langenhoven Drive Oncology Centre" in a lesser frequency.

Most popular intervention types in "Langenhoven Drive Oncology Centre" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Avastin" (1 trials), "BI 695502" (1 trials), "BIBF 1120 plus docetaxel" (1 trials) and "BIBW 2992" (1 trials). Other intervention names were less common.

The vast majority of trials in "Langenhoven Drive Oncology Centre" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Langenhoven Drive Oncology Centre". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Langenhoven Drive Oncology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Langenhoven Drive Oncology Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".